156 results
Page 5 of 8
8-K
EX-3.1
563ru3cykljr8edfuhx
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.18
f2t 7xb4r
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.2
499qwq0vqy6qk
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-3.2
zt90b80f89l4qjc5m gx
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
47iqsckuepzr 3z0
21 Jun 21
Other Events
4:04pm
425
evw l7mnddr67dko2y
21 Jun 21
Business combination disclosure
4:02pm
424B3
cn0r 7zwws9m
9 Jun 21
Prospectus supplement
4:42pm
8-K
ulcsmt1hxugy0eq
9 Jun 21
Other Events
4:40pm
8-K
EX-99.1
sxbl6hpkjwatbta2j5
9 Jun 21
Other Events
4:40pm
425
EX-99.1
3tqvygdm2df835 9vm
9 Jun 21
Business combination disclosure
4:38pm
425
8mby znr9p
9 Jun 21
Business combination disclosure
4:38pm
8-K
kcwse
4 Jun 21
POINT Biopharma Announces First Patients
4:22pm
8-K
EX-99.1
c3wm eluqyzet8fs
4 Jun 21
POINT Biopharma Announces First Patients
4:22pm
425
EX-99.1
tkzz0
4 Jun 21
Business combination disclosure
4:20pm
425
rappk vnogb1wk
4 Jun 21
Business combination disclosure
4:20pm
8-K
EX-99.1
ldhn4i82
1 Jun 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
4:32pm
8-K
p9atszf 5fcyzxum
1 Jun 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
4:32pm
425
EX-99.1
zev 4x97k1pk1lbd
1 Jun 21
Business combination disclosure
4:30pm
425
541cbcqawz3 i8uk
1 Jun 21
Business combination disclosure
4:30pm